Gábor Gy Deák1,2, Debra A Goldstein1, Mei Zhou1, Amani A Fawzi1, Lee M Jampol1. 1. Feinberg School of Medicine, Department of Ophthalmology, Northwestern University, Chicago, Illinois. 2. Department of Ophthalmology and Optometry, Medical University of Vienna, Vienna, Austria.
Abstract
Importance: Vitreoretinal lymphoma is a diagnostic challenge and the pathophysiology is still unclear. Objective: To describe an imaging finding seen on optical coherence tomography (OCT) of patients with vitreoretinal lymphoma. Design, Setting, and Participants: This case series study was a retrospective medical record review of patients who received a diagnosis of vitreoretinal lymphoma at the Department of Ophthalmology at Northwestern University between July 2014 and January 2016. Main Outcomes and Measures: Optical coherence tomography findings in vitreoretinal lymphoma. Results: We identified 7 patients (4 women [57.1%]; mean [range] age, 62.4 [45-75] years; 12 eyes) with intraocular lymphoma involving the retina (5 patients [71.4%] with primary vitreoretinal or central nervous system lymphoma with ocular involvement, 1 patient [14.3%] with testicular lymphoma with secondary central nervous system lymphoma and vitreoretinal lymphoma, and 1 patient [14.3%] with secondary vitreoretinal lymphoma). We identified vertical hyperreflective lesions that showed moderate or high reflectivity and affected all layers of the neuroretina in 5 patients (7 of 12 eyes [58.3%]). These often preceded the development of subretinal pigment epithelial deposits and were often localized around second-order and third-order retinal vessels. In most cases, they resolved with minimal or no scarring after the initiation of chemotherapy. Conclusions and Relevance: Vertical hyperreflective lesions are a common physical finding on OCT in eyes with vitreoretinal lymphoma.
Importance: Vitreoretinal lymphoma is a diagnostic challenge and the pathophysiology is still unclear. Objective: To describe an imaging finding seen on optical coherence tomography (OCT) of patients with vitreoretinal lymphoma. Design, Setting, and Participants: This case series study was a retrospective medical record review of patients who received a diagnosis of vitreoretinal lymphoma at the Department of Ophthalmology at Northwestern University between July 2014 and January 2016. Main Outcomes and Measures: Optical coherence tomography findings in vitreoretinal lymphoma. Results: We identified 7 patients (4 women [57.1%]; mean [range] age, 62.4 [45-75] years; 12 eyes) with intraocular lymphoma involving the retina (5 patients [71.4%] with primary vitreoretinal or central nervous system lymphoma with ocular involvement, 1 patient [14.3%] with testicular lymphoma with secondary central nervous system lymphoma and vitreoretinal lymphoma, and 1 patient [14.3%] with secondary vitreoretinal lymphoma). We identified vertical hyperreflective lesions that showed moderate or high reflectivity and affected all layers of the neuroretina in 5 patients (7 of 12 eyes [58.3%]). These often preceded the development of subretinal pigment epithelial deposits and were often localized around second-order and third-order retinal vessels. In most cases, they resolved with minimal or no scarring after the initiation of chemotherapy. Conclusions and Relevance: Vertical hyperreflective lesions are a common physical finding on OCT in eyes with vitreoretinal lymphoma.
Authors: Chi-Chao Chan; James L Rubenstein; Sarah E Coupland; Janet L Davis; J William Harbour; Patrick B Johnston; Nathalie Cassoux; Valerie Touitou; Justine R Smith; Tracy T Batchelor; Jose S Pulido Journal: Oncologist Date: 2011-11-01
Authors: Marcela Marsiglia; Roberto Gallego-Pinazo; Eduardo Cunha de Souza; Marion R Munk; Suquin Yu; Sarah Mrejen; Emmett T Cunningham; Brandon J Lujan; Naomi R Goldberg; Thomas A Albini; Alain Gaudric; Catherine Francais; Richard B Rosen; K Bailey Freund; Lee M Jampol; Lawrence A Yannuzzi Journal: Retina Date: 2016-01 Impact factor: 4.256
Authors: S A Grimm; J S Pulido; K Jahnke; D Schiff; A J Hall; T N Shenkier; T Siegal; N D Doolittle; T Batchelor; U Herrlinger; E A Neuwelt; N Laperriere; M C Chamberlain; J Y Blay; A J M Ferreri; A M P Omuro; E Thiel; L E Abrey Journal: Ann Oncol Date: 2007-09-05 Impact factor: 32.976
Authors: Robert J Barry; Anastasia Tasiopoulou; Philip I Murray; Praveen J Patel; Mandeep S Sagoo; Alastair K Denniston; Pearse A Keane Journal: Br J Ophthalmol Date: 2018-01-06 Impact factor: 4.638
Authors: Justine R Smith; Alexandra L Farrall; Janet L Davis; Joke H de Boer; Anthony J Hall; Manabu Mochizuki; H Nida Sen; Hiroshi Takase; Ninette H Ten Dam-van Loon; Valérie Touitou; Daniel V Vasconcelos-Santos; David J Wilson; Steven Yeh; Mark H B Radford Journal: BMJ Open Date: 2022-07-28 Impact factor: 3.006